The latest trading day saw CVS Health (CVS) settling at $79.12, representing a +1.38% change from its previous close.

An announcement from CVS Group plc ( ($GB:CVSG) ) is now available. CVS Group plc, the AIM-listed veterinary services provider with extensive ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read here for more analysis.

CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to ...

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

CVS Health’s (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock here.

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum behind the company's upcoming unified app.

CVS Group plc ( ($GB:CVSG) ) has shared an update. CVS Group plc has announced the purchase of 4,432 of its ordinary shares as part of a share ...

So you are wondering whether CVS Health at around $77.79 is still a smart buy after its big run, or if you are showing up late to the party, this breakdown will help you separate real value from just ...

Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic ...